Matthew Fair
Overview
Explore the profile of Matthew Fair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papasavvas E, Lu L, Fair M, Oliva I, Cassel J, Majumdar S, et al.
J Immunol
. 2024 Aug;
213(6):808-822.
PMID: 39109927
Type I IFNs play a pivotal role in immune response modulation, yet dysregulation is implicated in various disorders. Therefore, it is crucial to develop tools that facilitate the understanding of...
2.
Papasavvas E, Lu L, Fair M, Oliva I, Cassel J, Majumdar S, et al.
bioRxiv
. 2024 May;
PMID: 38746170
Type I interferons (IFNs) play a pivotal role in immune response modulation, yet dysregulation is implicated in various disorders. Therefore, it is crucial to develop tools that facilitate the understanding...
3.
Tebas P, Lynn K, Azzoni L, Cocchella G, Papasavvas E, Fair M, et al.
AIDS
. 2023 Apr;
37(8):1203-1207.
PMID: 37070542
Objective: The aim of this study was to assess the susceptibility of HIV to two HIV monoclonal antibodies (bnAbs), 3BNC117 and 10-1074, in individuals with chronically antiretroviral therapy (ART) suppressed...
4.
Azzoni L, Giron L, Vadrevu S, Zhao L, Lalley-Chareczko L, Hiserodt E, et al.
J Leukoc Biol
. 2022 Aug;
112(4):733-744.
PMID: 35916053
Opioid use has negative effects on immune responses and may impair immune reconstitution in persons living with HIV (PLWH) infection undergoing antiretroviral treatment (ART). The effects of treatment with μ...
5.
Papasavvas E, Azzoni L, Ross B, Fair M, Howell B, Hazuda D, et al.
AIDS
. 2021 May;
35(12):2051-2054.
PMID: 34049356
We report on the post-hoc analysis of three clinical studies (NCT01935089, NCT00594880 and NCT00051818) with chronically HIV-infected, immune-reconstituted individuals with similar entry criteria, and demographics interrupting antiretroviral therapy (ART) without...
6.
Papasavvas E, Azzoni L, Ross B, Fair M, Yuan Z, Gyampoh K, et al.
Clin Infect Dis
. 2021 Feb;
72(3):495-498.
PMID: 33527127
Accurate characterization of the human immunodeficiency virus (HIV) reservoir is imperative to develop an effective cure. HIV was measured in antiretroviral therapy-suppressed individuals using the intact proviral DNA assay (IPDA),...
7.
Papasavvas E, Azzoni L, Pagliuzza A, Abdel-Mohsen M, Ross B, Fair M, et al.
AIDS Res Hum Retroviruses
. 2020 Dec;
37(6):433-443.
PMID: 33323024
In the pilot NCT01935089 trial, we tested whether pegylated interferon alpha2b (Peg-IFN-α2b) with antiretroviral therapy (ART) was safe and could impact HIV and immune measures in blood and in gut-associated...
8.
Giron L, Colomb F, Papasavvas E, Azzoni L, Yin X, Fair M, et al.
EBioMedicine
. 2020 Aug;
59:102945.
PMID: 32827942
Background: A comprehensive understanding of host factors modulated by the antiviral cytokine interferon-α (IFNα) is imperative for harnessing its beneficial effects while avoiding its detrimental side-effects during HIV infection. Cytokines...
9.
Giron L, Azzoni L, Yin X, Lynn K, Ross B, Fair M, et al.
AIDS
. 2020 Jul;
34(10):1461-1466.
PMID: 32675559
Objective: Glycosylation plays a critical role in mediating several antibody (mainly immunoglobulin G; IgG) immunological functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), and anti-inflammatory activities. We investigated whether IgG glycosylation and...
10.
Papasavvas E, Azzoni L, Kossenkov A, Dawany N, Morales K, Fair M, et al.
J Immunol
. 2019 Jun;
203(3):705-717.
PMID: 31253727
We previously reported that pegylated IFN-α2a (Peg-IFN-α2a) added to antiretroviral therapy (ART)-suppressed, HIV-infected subjects resulted in plasma HIV control and integrated HIV DNA decrease. We now evaluated whether innate NK...